Psychiatric Illness and Obesity: Recognizing the "Obesogenic" Nature of an Inpatient Psychiatric Setting

Faculty of Physical Education and Health, University of Toronto, 55 Harbord St., Toronto, Ontario, Canada.
Psychiatric services (Washington, D.C.) (Impact Factor: 2.41). 05/2009; 60(4):538-41. DOI: 10.1176/
Source: PubMed


The prevalence of obesity and obesity-related diseases is higher among individuals with psychiatric illness than in the general population. This study examined environmental factors that contribute to obesity in one psychiatric hospital in Canada.
Semistructured interviews were conducted with 25 key stakeholders from multiple professional disciplines at the hospital. Transcribed interviews were analyzed through content analysis with the analysis grid for environments linked to obesity (ANGELO) framework as a categorical template.
Factors contributing to obesity in this setting were related to increased energy intake, such as easy access to high-calorie snacks and beverages, and reduced energy expenditure, such as lack of access to staircases.
Psychiatric settings may contribute to the high prevalence of obesity among individuals with psychiatric illness. Ecologically framed interventions are required to address obesity in this population.

Full-text preview

Available from:
  • Source
    • "4. Need to take into account factors such as transport and the cost of health promotion. 5. Address oesogei hospital ad reoery ad reha eiroets (Faulkner, Gorczynski et al 2009). 6. Sustained interventions (example of free fruit and vegetables: no effect after intervention ceased). "
    [Show description] [Hide description]
    DESCRIPTION: SA govt commissioned health promotion/workforce capacity building project for the implementation of Eat Well Be Active in the disability sector.
    Full-text · Research · Feb 2015
  • Source
    • "Diabetes associated comorbid psychopathologies are the major causes of health care costs of diabetes (Hutter et al., 2010) and available psychotherapeutics do not appropriately meet the therapeutic demands of diabetic patients. Moreover, many currently available psycho active drugs possess obesogenic potentials, and obesity is a major risk factor of insulin resistance and type 2 diabetes (Faulkner et al., 2009; Pan et al., 2012). It is now well recognized that diabetes and psychiatric disorders share a bidirectional association (Balhara, 2011), and that the gut-central nervous system could as well be the target for nutritional therapies (Pimentel et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Brassica juncea is a polyphenols enriched edible plant, with diverse medicinal uses of different parts of which have been mentioned in the Ayurveda. The effects of 10 daily oral doses (100, 200, and 400 mg/kg/day) of a methanolic Brassica juncea leaf extract in rat models of anxiety using nondiabetic and alloxan-diabetic rats were quantified. In all the three behavioural tests used, i.e. elevated plus maze, open field, and social interaction tests, anxiolytic-like activity of the extract was observed in the diabetic animals only. Quantitatively, the efficacy of the highest tested dose of the extract in these tests was always less than those observed after its lower ones. These observations provide further experimental evidences for the conviction that Brassica vegetables could as well be useful for combating diabetes associated mental health problems.
    Full-text · Article · Feb 2013

  • No preview · Article · Aug 2010 · Schizophrenia Research
Show more